180 related articles for article (PubMed ID: 18404659)
1. Manipulating the anabolic and catabolic response in bone graft remodeling: synergism by a combination of local BMP-7 and a single systemic dosis of zoledronate.
Harding AK; Aspenberg P; Kataoka M; Bylski D; Tägil M
J Orthop Res; 2008 Sep; 26(9):1245-9. PubMed ID: 18404659
[TBL] [Abstract][Full Text] [Related]
2. Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density: a bone chamber study in rats.
Belfrage O; Flivik G; Sundberg M; Kesteris U; Tägil M
Acta Orthop; 2011 Apr; 82(2):228-33. PubMed ID: 21434769
[TBL] [Abstract][Full Text] [Related]
3. Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling.
Tägil M; Aspenberg P; Astrand J
Acta Orthop; 2006 Feb; 77(1):23-6. PubMed ID: 16534698
[TBL] [Abstract][Full Text] [Related]
4. Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats.
Astrand J; Harding AK; Aspenberg P; Tägil M
BMC Musculoskelet Disord; 2006 Aug; 7():63. PubMed ID: 16889666
[TBL] [Abstract][Full Text] [Related]
5. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
[TBL] [Abstract][Full Text] [Related]
7. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model.
Mathavan N; Bosemark P; Isaksson H; Tägil M
Bone; 2013 Oct; 56(2):440-8. PubMed ID: 23845325
[TBL] [Abstract][Full Text] [Related]
8. Bone graft incorporation. Effects of osteogenic protein-1 and impaction.
Tägil M; Jeppsson C; Aspenberg P
Clin Orthop Relat Res; 2000 Feb; (371):240-5. PubMed ID: 10693571
[TBL] [Abstract][Full Text] [Related]
9. The morselized and impacted bone graft. Animal experiments on proteins, impaction and load.
Tägil M
Acta Orthop Scand Suppl; 2000 Feb; 290():1-40. PubMed ID: 10745934
[TBL] [Abstract][Full Text] [Related]
10. Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2.
Ichikawa K; Ohta Y; Mamoto K; Mizokawa S; Minoda Y; Imai Y; Takaoka K; Nakamura H
Biochem Biophys Res Commun; 2016 Nov; 480(3):314-320. PubMed ID: 27746180
[TBL] [Abstract][Full Text] [Related]
11. A combination of bisphosphonate and BMP additives in impacted bone allografts.
Jeppsson C; Astrand J; Tägil M; Aspenberg P
Acta Orthop Scand; 2003 Aug; 74(4):483-9. PubMed ID: 14521303
[TBL] [Abstract][Full Text] [Related]
12. Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats.
Belfrage O; Isaksson H; Tägil M
BMC Musculoskelet Disord; 2012 Dec; 13():240. PubMed ID: 23217097
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor enhances bone-graft incorporation: dose and time dependence in rats.
Wang JS; Aspenberg P
J Orthop Res; 1996 Mar; 14(2):316-23. PubMed ID: 8648512
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength.
Bosemark P; Isaksson H; McDonald MM; Little DG; Tägil M
Acta Orthop; 2013 Feb; 84(1):106-11. PubMed ID: 23409846
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
[TBL] [Abstract][Full Text] [Related]
16. Prediction of bone density around orthopedic implants delivering bisphosphonate.
Stadelmann VA; Terrier A; Gauthier O; Bouler JM; Pioletti DP
J Biomech; 2009 Jun; 42(9):1206-11. PubMed ID: 19380139
[TBL] [Abstract][Full Text] [Related]
17. Modulation of allograft incorporation by continuous infusion of growth factors over a prolonged duration in vivo.
Ma T; Gutnick J; Salazar B; Larsen MD; Suenaga E; Zilber S; Huang Z; Huddleston J; Smith RL; Goodman S
Bone; 2007 Sep; 41(3):386-92. PubMed ID: 17613298
[TBL] [Abstract][Full Text] [Related]
18. Experimental results of combining bisphosphonates with allograft in a rat model.
Agholme F; Aspenberg P
J Bone Joint Surg Br; 2009 May; 91(5):670-5. PubMed ID: 19407306
[TBL] [Abstract][Full Text] [Related]
19. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
20. The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects.
Park J; Lutz R; Felszeghy E; Wiltfang J; Nkenke E; Neukam FW; Schlegel KA
Biomaterials; 2007 Jun; 28(17):2772-82. PubMed ID: 17339051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
